✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Nectar Lifesciences Ltd.

NECLIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹374 Cr.
P/E
0.00

Nectar Lifesciences Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
374 Cr
PE
PE
-
Prom Holding
Prom Holding
44.53 %
ROE (%)
ROE (%)
0.47
ROCE (%)
ROCE (%)
9.51
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1,594 Cr
OPM (%)
OPM (%)
-8.04 %
Debt to Equity
Debt to Equity
0.59
View more
Edit Ratio's

About

Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of… Read more
Low
13
52W Range
High
48
  • Nectar Lifesciences
  • Haleos Labs
  • Everest Organics
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Global DMFs filed (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • IOL Chemicals And Pharmaceuticals Ltd.

    FAQs on Nectar Lifesciences Ltd. Business

    Nectar Lifesciences is a key player in the Indian Pharmaceutical Industry, specializing in Global Cephalosporins within Anti Infective Therapeutic segment. The company is expanding globally by entering regulated markets like US and European Union.

    Nectar Lifesciences major competitors are Haleos Labs, Everest Organics, Smruthi Organics, Tyche Inds, Bal Pharma, Mangalam Drugs&Org., Lasa Supergenerics.
    Market Cap of Nectar Lifesciences is ₹374 Crs.
    While the median market cap of its peers are ₹147 Crs.

    Nectar Lifesciences seems to be less financially stable compared to its competitors.
    Altman Z score of Nectar Lifesciences is 1.91 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Dec Dec
    Investor Presentation Sep Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material